Dr. Philip Flemming Pacelli III

Dr. Philip Flemming Pacelli III(DR. PHILIP FLEMMING PACELLI III) is Oral Oral & Maxillofacial Surgery Physician in New Canaan, CT. The NPI Number for Dr. Philip Flemming Pacelli III is 1699890723.

The current location address for Dr. Philip Flemming Pacelli III is 166 CHERRY STREET SUITE A New Canaan, CT 06840 and the contact number is 2039721581 and fax number is 2039721980. The mailing address for Dr. Philip Flemming Pacelli III is 166 CHERRY STREET SUITE A New Canaan, CT 06840- 2039721581 (mailing address contact number - 2039721581).

Oral and maxillofacial surgeons are trained to recognize and treat a wide spectrum of diseases, injuries and defects in the head, neck, face, jaws and the hard and soft tissues of the oral and maxillofacial region. They are also trained to administer anesthesia, and provide care in an office setting. They are trained to treat problems such as the extraction of wisdom teeth, misaligned jaws, tumors and cysts of the jaw and mouth, and to perform dental implant surgery.

What is the NPI Number for Dr. Philip Flemming Pacelli III?

Answer: The NPI Number for Dr. Philip Flemming Pacelli III is 1699890723

Where is Dr. Philip Flemming Pacelli III located?

Answer: Dr. Philip Flemming Pacelli III is located at 166 CHERRY STREET SUITE A New Canaan, CT 06840.

What is the specialty for Dr. Philip Flemming Pacelli III?

Answer: The Specialty of Dr. Philip Flemming Pacelli III is Oral Oral & Maxillofacial Surgery Physician.

Are there any online reviews for Dr. Philip Flemming Pacelli III?

Answer: Yes! Check It Now.

Are there any other health care providers in New Canaan, CT?

Answer: Yes, there are given below...

Information on prescription drugs provided to Medicare beneficiaries enrolled in Part D (Prescription Drug Coverage), by physicians and other health care providers, aggregated by provider.

Provider Specialty Type	Oral & Maxillofacial Surgery
Source of Provider Specialty
Number of Medicare Part D Claims, Including Refills	605
Number of Standardized 30-Day Fills	605.86666667
Aggregate Cost Paid for All Claims	3668.93
Number of Day's Supply for All Claims	5310
Number of Medicare Beneficiaries	242
Number of Claims, Including Refills, for Beneficiaries Age 65+
Including Refills, for Beneficiaries Age 65+
Beneficiaries Age 65+
Number of Day's Supply for All Claims for Beneficaries Age 65+
Number of Medicare Beneficiaries Age 65+
Reason for Suppression of Brnd_Tot_Clms and Brnd_Tot_Drug_Cst	*
Total Claims of Brand-Name Drugs
Reason for Suppression of Gnrc_Tot_Clms and Gnrc_Tot_Drug_Cst
Total Claims of Generic Drugs, Including Refills	600
Aggregate Cost Paid for Generic Drugs	3626.06
Reason for Suppression of Othr_Tot_Clms and Othr_Tot_Drug_Cst	#
Total Claims of Other Drugs, Including Refills
Aggregate Cost Paid for Other Drugs
Reason for Suppression of MAPD_Tot_Clmsand MAPD_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by MAPD Plans	102
Aggregate Cost Paid for Claims Filled by Beneficiaries in MAPD Plans	401.84
Reason for Suppression of PDP_Tot_Clms and PDP_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by Standalone PDP Plans	503
Aggregate Cost Paid for Claims Filled by	3267.09
Reason for Suppression of LIS_Tot_Clms and LIS_Drug_Cst
Number of Claims for Beneficiaries Covered by Low-Income Subsidy	48
Aggregate Cost Paid for Claims Covered by Low-Income Subsidy	204.54
Reason for Suppression of NonLIS_Tot_Clms and NonLIS_Drug_Cst
Number of Claims for Beneficiaries Not Covered by Low-Income Subsidy	557
by Low-Income Subsidy	3464.39
Total Claims of Opioid Drugs, Including	85
Aggregate Cost Paid for Opioid Drugs	210.71
Opioid Claims	78
Opioid_Tot_Clms divided by the Tot_Clms	14.049586777
Total Claims of Long-Acting Opioid Drugs	0
Aggregate Cost Paid for Long-Acting Opioid	0
Number of Day's Supply of All Long-Acting	0
Long-Acting Opioid Claims	0
Opioid_LA_Tot_Clms divided by the	0
Total Claims of Antibiotic Drugs, Including	337
Aggregate Cost Paid for Antibiotic Drugs	2007.58
Antibiotic Claims	231
Reason for Suppression of Antpsyct_GE65_Tot_Clms and Antpsyct_GE65_Tot_Drug_Cst	*
Including Refills, for Beneficiaries Age 65+
Aggregate Cost Paid for AntipsychoticDrugs for Beneficiaries Age 65+
Reason for Suppression of Antpsyct_GE65_Tot_Benes
Number of Medicare Beneficiaries Age 65+Filling Antipsychotic Claims
Average Age of Beneficiaries	76.900826446
Number of Beneficiaries Age Less Than 65
Number of Beneficiaries Age 65 to 74
Number of Beneficiaries Age 75 to 84
Number of Female Beneficiaries	118
Number of Male Beneficiaries	124
Number of Non-Hispanic White	223
Number of Black or African American	0
Number of Asian Pacific Islander
Number of Hispanic Beneficiaries
Number of American Indian/Alaskan NativeBeneficiaries	0
Number of Beneficiaries with Race Not	13
Only Entitlement
Average Hierarchical Condition Category	0.9516089272